A study of R&amp;D, innovation, and business performance in the Canadian biotechnology industry

Hall, Linda A.; Bagchi‐Sen, Sharmistha

doi:10.1016/s0166-4972(01)00016-5

Cited by 223 publications

(122 citation statements)

References 7 publications

Supporting

Mentioning

117

Contrasting

Unclassified

Order By: Relevance

“…We limit our sample to this industry because the propensity to patent is high, making patent data appropriate indicators of technological activity (Hall and Bagchi-Sen 2002;Porkolab 2002). The pharma sector provides an interesting sector for our study because it is characterised by a widely dispersed knowledge infrastructure in which both small and large firms play an important role.…”

Section: Samplementioning

confidence: 99%

“…In this sector, new technological opportunities often emerge from small high-tech biotechnology firms, companies tend to engage in a wide array of relationships in order to build a 'radar-function' on new technologies. Therefore, given the technological challenges, opportunities and costs of bringing new products to the market, companies in these sectors are extensively involved in strategic alliances with a variety of external partners (Hall and Bagchi-Sen 2002;McKelvey, Alm, and Riccaboni 2003). In particular, large pharmaceutical firms are building a large portfolio of relationships.…”

Section: Samplementioning

confidence: 99%

See 1 more Smart Citation

Complementarity in alliance portfolios and firm innovation

Sabidussi

Lokshin

Duijsters

2017

Industry and Innovation

View full text Add to dashboard Cite

This paper assesses the impact on firm innovation of combining alliance-specific and partner-specific attributes within a firm's alliance portfolio. In a panel data analysis of the innovation performance of 119 firms operating in the pharmaceutical industry during 1985-2007, we test whether firm's alliance portfolio displays complementarities across four dimensions. The results suggest that specific combinations of attributes may diminish innovation by decreasing the efficiency of diversity management or by generating redundancies. On the other hand, other alliance portfolio practices are mutually reinforcing and thus foster innovation.

show abstract

Section: Samplementioning

confidence: 99%

Section: Samplementioning

confidence: 99%

Complementarity in alliance portfolios and firm innovation

Sabidussi

Lokshin

Duijsters

2017

Industry and Innovation

View full text Add to dashboard Cite

show abstract

“…Megna and Klock (1993), Ernst et al (2010), and Suzuki (2011) measured patent indicators and business performance. Other studies have discussed various R&D input indicators, including R&D expenditure (R&D intensity or technological overflow), R&D technology sources (self-innovation, introduction for modification, partial introduction, total introduction and returns of royalty) and R&D output (number of patents and the number of new products to the market) (Thomas 2001;Watanabe et al 2001;Hall, Bagchi-Sen 2002;Schoenecker, Swanson 2002;Reitzig 2003;Tseng, Wu 2007).…”

Section: Literature Reviewmentioning

confidence: 99%

How Does Patent Litigation Influence Dynamic Risk for Market Competitors?

Wang

Lin

et al. 2015

Technological and Economic Development of Economy

View full text Add to dashboard Cite

Abstract. Many recent studies have discussed the appropriateness of various patent measurement indicators, as well as the differences in the positioning of patented technologies, while there is little discussion on the risk transmission of enterprises when faced with infringement litigation. This study used the bivariate EGARCH (Exponential Generalized Autoregressive Conditional Heteroskedasticity) model with DCC (Dynamic Conditional Correlations) to investigate the dynamic risk transmission of patent litigation between market competitors in the smartphone industry. Empirical results revealed that when facing lawsuits from market challengers, the market leader faces fewer risks when handling patent infringement litigations. In addition, the risk reactions of competitors during patent wars may widely differ. Investors should consider the patent infringement litigations when measuring the dynamic risks of share prices, and determining the optimal configuration of asset portfolios in response.

show abstract

“…Expense of research and development is usually viewed as the input of technology ability (Griliches, 1990), since financial resource investing is the first stage to create new products or development new technology. However, there exists some problems, firstly, the uncertainty of research and development is high, and creating new product or new process takes a long time form investment to the market (Hall & Bagchi-Sen, 2002). Secondly, the output of research and development often contains great ambiguous, and it could not be identified and evaluating.…”

Section: Innovation Abilitymentioning

confidence: 99%

“…Secondly, the output of research and development often contains great ambiguous, and it could not be identified and evaluating. Thirdly, the process of innovation is very complicated, it crosses several function from research, prototype development, commercialization, and to the end of market (Hall & Bagchi-Sen, 2002). The benefit might be revealed after several years.…”

Section: Innovation Abilitymentioning

confidence: 99%

Corporate Governance and Innovation Ability: Empirical Study of Taiwanese Electronics Manufactures

Tseng

Wu²,

Lin³

2013

IBR

View full text Add to dashboard Cite

Since corporate scandals in the last decade, corporate governance system has been highly focused, besides, now under knowledge-based economy the innovation ability of enterprises is a key factor to enterprise's success. However, how the board of directors effects firms' innovation ability has been rarely explored. Generally, it is thought that corporate governance could provide functions to bring stakeholders the greatest profit and have better operating efficiency. Precious study proved that corporate governance is related to corporate performance. This study discusses the relationship between board of directors and the firm's innovation ability, including size of board directors, proportion of shareholding and traits of board of directors. By using patent counts as an index to measure a firm's innovation ability, this study examined 255 public listed electronic firms in Taiwan by using unbalanced 5 year panel data. This study adopts one way fixed effect model to evaluate parameters of model, and use F-test to examine the explanatory power of a model. Finally, this study shows how the corporate governance system affects firms' innovation ability, and provides suggestion that how corporate governance system, board directors and other traits are effective in firms innovation ability.

show abstract

A study of R&D, innovation, and business performance in the Canadian biotechnology industry

Cited by 223 publications

References 7 publications

Complementarity in alliance portfolios and firm innovation

Complementarity in alliance portfolios and firm innovation

How Does Patent Litigation Influence Dynamic Risk for Market Competitors?

Corporate Governance and Innovation Ability: Empirical Study of Taiwanese Electronics Manufactures

Contact Info

Product

Resources

About